Office of the Vice President for Research

EvolveImmune

EvolveImmune logo

EvolveImmune Therapeutics is rapidly transforming the discovery and development of novel immunotherapies. By leveraging its proprietary in vivo targe discovery platform, EvolveImmune is building a pipeline of novel therapeutic candidates against numerous targets which are expressed on multiple immune cell types. The company's platform will generate first-in-class treatments for unmet needs in oncology and autoimmune diseases. 

Contact: 

Rebecca Frey - COO